DK0587121T3 - Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf - Google Patents

Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf

Info

Publication number
DK0587121T3
DK0587121T3 DK93114343T DK93114343T DK0587121T3 DK 0587121 T3 DK0587121 T3 DK 0587121T3 DK 93114343 T DK93114343 T DK 93114343T DK 93114343 T DK93114343 T DK 93114343T DK 0587121 T3 DK0587121 T3 DK 0587121T3
Authority
DK
Denmark
Prior art keywords
cefepime
cephalosporine
dihydrochloride dihydrate
crystalline dihydrochloride
dihydrochloride salt
Prior art date
Application number
DK93114343T
Other languages
Danish (da)
English (en)
Inventor
Munir N Nassar
Gary M F Lim
Elizabeth Ann Garofalo
Murray Arthur Kaplan
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0587121T3 publication Critical patent/DK0587121T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK93114343T 1992-09-08 1993-09-07 Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf DK0587121T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94158492A 1992-09-08 1992-09-08
US94159192A 1992-09-08 1992-09-08

Publications (1)

Publication Number Publication Date
DK0587121T3 true DK0587121T3 (da) 1999-07-26

Family

ID=27130161

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93114343T DK0587121T3 (da) 1992-09-08 1993-09-07 Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf

Country Status (9)

Country Link
EP (1) EP0587121B1 (ja)
JP (1) JP3868008B2 (ja)
AT (1) ATE173265T1 (ja)
AU (1) AU671658B2 (ja)
CA (1) CA2101571A1 (ja)
DE (1) DE69322030T2 (ja)
DK (1) DK0587121T3 (ja)
ES (1) ES2124279T3 (ja)
GR (1) GR3029306T3 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
JP2914324B2 (ja) 1995-10-23 1999-06-28 味の素株式会社 ピペリジン誘導体の結晶並びにその製造中間体及び製造方法
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
CA2591157C (en) * 2004-12-17 2012-06-12 Venus Remedies Limited Antibiotic combinations for providing total solution to the treatment of infections
ATE489380T1 (de) * 2006-02-10 2010-12-15 Amgen Inc Hydratformen von amg706
CN102351885B (zh) * 2011-08-19 2012-08-22 深圳立健药业有限公司 用于制备头孢呋辛-l-精氨酸水合物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457295A1 (fr) * 1979-05-25 1980-12-19 Glaxo Group Ltd Composes intermediaires pour la preparation de cephalosporines
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
IL76367A0 (en) * 1984-09-17 1986-01-31 Lilly Co Eli Improved process for cephalsporin intermediates
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate

Also Published As

Publication number Publication date
GR3029306T3 (en) 1999-05-28
JPH06192271A (ja) 1994-07-12
DE69322030T2 (de) 1999-07-15
JP3868008B2 (ja) 2007-01-17
ES2124279T3 (es) 1999-02-01
AU671658B2 (en) 1996-09-05
EP0587121B1 (en) 1998-11-11
DE69322030D1 (de) 1998-12-17
AU4616493A (en) 1994-03-17
ATE173265T1 (de) 1998-11-15
EP0587121A1 (en) 1994-03-16
CA2101571A1 (en) 1994-03-09

Similar Documents

Publication Publication Date Title
AR005597A1 (es) Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados.
EP0472060A3 (en) Antibiotic c-7 catechol-subtituted cephalosporin compounds, compositions, and use thereof
IT8947539A0 (it) Sali cefalosporinici e relative composizioni iniettabili, nonche' procedimento di preparazione
DK454086A (da) Quinolinderivater og deres anvendelse
PT992509E (pt) Novos derivados macrolidos
ES2111930T3 (es) Antagonistas del acido amp y procedimientos de tratamiento con la ayuda de estos.
DE69103490D1 (de) Cephalosporinderivate mit in der Lage 3 eine Thioalkylthiogruppe.
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
DK0587121T3 (da) Krystallinsk dihydrat af et cephalosporindihydrochloridsalt og injicerbare præparater deraf
IL103818A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
KR950700293A (ko) 세로토닌작동성의 에르골린 유도체(Serotoninergic ergoline derivatives)
DK0388049T3 (da) Penciclovirderivater til behandling af hepatitis B infektioner
FI931703A (fi) Anordning foer uppbaerande av ett flaekthus med hjaelp av en elastisk ring
NO923983D0 (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og deres terapeutiske anvendelse
FI862566A (fi) Foerfarande foer framstaellning av nya penemderivat.
ES449688A1 (es) Procedimiento para la preparacion de un acido 7-(alfa-amino-w-(3, 4-metilenodioxifenil) acilamido) cefalosporanico.
DK536986A (da) Cephalosporinderivater, deres fremstilling og anvendelse
ATA294388A (de) Kristallines, schwerloesliches hydrojodisadditionssalz von 7-amino-3-(4-carbamoyl-1chinuclidinium)methyl-3-cephem-4-carboxylat
NO884486L (no) Fremgangsmaate for fremstilling av cefalosporinderivater med forbedrede farmakokinetika.
ITMI910517A0 (it) Composizione solida stabilizzante
DK0540107T3 (da) Klinkerproduktionsanlæg
ATE111099T1 (de) Ergolinderivate.
BG97117A (bg) Цефалоспоринови производни
NO890341D0 (no) Produksjon av alkaloider med hoey renhet.
UA26433A (uk) Спосіб отримаhhя аміhотіазолільhих похідhих цефалоспориhу та їх солей